Comerica Bank reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 272,080 shares of the healthcare conglomerate’s stock after selling 1,943 shares during the period. Comerica Bank’s holdings in UnitedHealth Group were worth $66,618,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Exane Derivatives grew its holdings in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after acquiring an additional 460 shares during the period. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $114,000. Acrospire Investment Management LLC grew its holdings in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the period. Jacobi Capital Management LLC grew its holdings in UnitedHealth Group by 6.6% during the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock worth $136,000 after acquiring an additional 45 shares during the period. Finally, Intellectus Partners LLC grew its holdings in UnitedHealth Group by 18.2% during the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after acquiring an additional 126 shares during the period. 86.83% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have weighed in on UNH. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Cantor Fitzgerald reiterated a “buy” rating and set a $280.00 price target on shares of UnitedHealth Group in a report on Thursday, March 8th. Barclays began coverage on UnitedHealth Group in a report on Thursday, March 8th. They set an “overweight” rating and a $265.00 price target for the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target for the company in a report on Saturday, January 20th. Finally, Argus increased their price target on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 18th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $245.14.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.11 EPS. equities research analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.58%.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,400 shares of UnitedHealth Group stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $229.87, for a total transaction of $2,390,648.00. Following the completion of the transaction, the director now owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total value of $2,377,600.00. Following the transaction, the director now owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. Insiders have sold a total of 53,196 shares of company stock valued at $12,291,179 in the last quarter. Company insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Comerica Bank Has $66.62 Million Position in UnitedHealth Group Inc (UNH)” was published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/14/comerica-bank-has-66-62-million-position-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.